Elanco Unveils Impact Report, Paving Path for Future Growth
Elanco's Commitment to Animal Health Report
Elanco Animal Health Incorporated (NYSE: ELAN) is proud to announce the availability of its 2024 Impact Report. This comprehensive document reflects Elanco's continuous effort to not only enhance animal care but also improve the overall experience for those who care for them. The report showcases a new strategic framework focused on four essential communities of impact, reinforcing Elanco's commitment to 'Going Beyond' for animals, customers, society, and its people.
A New Framework of Impact
The 2024 Impact Report serves as a testament to Elanco's relentless pursuit of positive change through innovative solutions. Within its pages, Elanco outlines eight ambitious goals designed to engender lasting positive effects on communities globally. This strategic approach reflects a strong alignment between the company's purpose and its operational practices.
Key Highlights from the Report
Among the many highlights included in the report, several key themes emerge, showcasing Elanco's achievements and initiatives:
Going Beyond for Animals
Elanco's commitment to animal welfare remains unwavering, and it is evidenced by several significant milestones:
- Successful launch of innovative products such as Zenrelia, Credelio Quattro, and Pradalex, which collectively generated an impressive $461 million in revenue in 2024, exceeding the target revenue from innovation.
- Expanded access for pet owners to essential parasite protection with strong market positioning as the leading retail parasiticide provider in the U.S. Additionally, global offerings were enhanced with the introduction of AdTab and the launch of Pet Protect, a new line of veterinary-formulated pet supplements.
- Generous contributions exceeding $400,000 in product donations through strategic partnerships aimed at supporting animal health and well-being.
- Recognition as an inaugural signatory to the U.S. Animal Research Openness Agreement, highlighting Elanco's commitment to transparency in research practices.
Going Beyond for Customers
Elanco's dedication to providing value through customer advocacy and innovative solutions is also a central theme:
- Introduction of Bovaer®, a groundbreaking methane-reducing feed ingredient for lactating dairy cattle, setting new sustainability standards.
- Achieved FDA approval for three combination clearances enhancing livestock sustainability, particularly focused on Experior use with MGA® in finishing heifers.
- Engagement of 11% of the U.S. dairy herd through the Elanco's UpLook database, which aids farmers in achieving sustainability goals and monetizing their carbon credit reductions.
- Investment of $310,000 in scholarships, designed to support aspiring students in veterinary science and animal health careers.
Going Beyond for Society
Elanco's societal contributions emphasize the importance of health and welfare:
- Education of nearly 150 global producers via the Elanco Food Safety Programme to combat Salmonella in poultry.
- Over 730 volunteer hours dedicated to food security efforts resulting in more than 115,000 meals packed in collaboration with local organizations.
- Successful recovery of counterfeit products valued at over $7 million and removal of numerous fraudulent online advertisements since 2021.
- Strategic collaboration with Medgene to harness advanced vaccine technologies aimed at commercializing highly pathogenic virus vaccines.
Going Beyond for Our People
Elanco emphasizes its human capital, recognizing the importance of a motivated workforce:
- Reported a noteworthy 71% Employee Engagement Score in the first quarter of 2025, a 4% increase compared to the previous year.
- Contributed more than 26,000 volunteer hours in 2024, equating to an estimated economic impact of $870,000 across numerous organizations.
- Implemented a global machine safety campaign, yielding a significant 37% reduction in workplace incidents related to health and safety issues.
- Improved energy efficiency at its Kiel facility and achieved a commitment to generating renewable green energy and neutralizing natural gas use.
Elanco encourages all stakeholders to delve into the complete details of the 2024 Impact Report, reflecting the company's unwavering pledge to 'Making Life Better' for animals, customers, society, and its people in every action they undertake.
About Elanco
Elanco Animal Health Incorporated (NYSE: ELAN) stands at the forefront of the animal health industry, committed to delivering innovative solutions for the prevention and treatment of diseases affecting farm animals and pets. With a rich history spanning over 70 years, Elanco is unwavering in its mission to enhance the health outcomes for animals and contribute positively to the broader communities. Guided by the vision of Food and Companionship Enriching Life, Elanco continues to strive for excellence in serving both customers and society at large.
Frequently Asked Questions
What is the main focus of Elanco's 2024 Impact Report?
The report emphasizes Elanco's commitment to enhancing animal care and the welfare of those who care for them through a new framework centered on key impact communities.
How does Elanco measure its success in innovation?
Elanco measures success through revenue generated from innovative products, with the goal set for increased revenue contribution from new product launches.
What initiatives does Elanco undertake for community support?
Elanco undertakes various community support initiatives, including product donations, educational programs, and efforts combating food safety issues.
How does Elanco enhance employee engagement?
The company focuses on creating a supportive work environment that encourages involvement, with a notable increase in employee engagement scores over the past year.
What are Elanco's future goals?
Elanco aims to continue advancing its impact reporting, enhance community engagement, and develop innovative solutions that benefit animals, customers, and society.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.